Key result
Patients identified lack of knowledge, poor communication with healthcare professionals, and difficulty accessing medications as key barriers to the safe and effective use of direct oral anticoagulants.
Why the study?
DOACs are high-risk medications used to prevent thromboembolic events and stroke, but patient views, experiences, and factors promoting their safety needed examination.
Patients taking DOACs face significant barriers to safe use and adherence, including lack of knowledge, poor communication with healthcare providers, and issues with drug availability, highlighting the need for targeted educational interventions.
Answers are grounded in this paper and cite their sources.
May guide targeted DOAC education and access improvements; leaves open whether interventions enhance adherence or safety.
BACKGROUND: Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients' views and experiences of DOACs use and factors that can promote safety associated with DOACs. METHODS: In-depth interviews were conducted with adult patients who had been prescribed DOACs, identified and invited by local collaborators in three different tertiary care hospitals in Saudi Arabia. A topic guide developed based on was used to inform the interview. Data were analysed thematically. RESULTS: Data saturation was achieved by the ninth participants. Three major themes were identified: (1) factors affecting DOAC's safety from the patients view; (2) barriers to adherence to DOACs and (3) strategies to promote the safety of DOACs. Lack of knowledge of DOACs, using inappropriate sources of information, lack of communication with HCPs, difficulty in having access to DOACs and lack of monitoring were the main factors affecting the safe use of DOACs. Unavailability of the drugs and difficulty in timely getting to hospitals affected adherence. Patients acknowledged difficulties communicating with healthcare professionals, timely access to anticoagulation clinics and in obtaining their DOACs on time. CONCLUSIONS: There is a need to develop and evaluate theory-based interventions to promote patient knowledge, understanding and shared decision-making to optimise DOACs use and improve their safety.
No takes yet. Share an insight, caveat, or question.
Rowily et al. (2023) studied Patients prescribed direct oral anticoagulants (n=9). Direct oral anticoagulants (DOACs) was evaluated. Patients identified lack of knowledge, poor communication with healthcare professionals, and difficulty accessing medications as key barriers to the safe and effective use of direct oral anticoagulants.
Synapse has enriched 10 related papers. Consider them for comparative context: